bluebird bio to split into oncology and gene therapy specialists
pharmaphorum
JANUARY 11, 2021
US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market. They will also be better at raising money with tailored investment theses and increased strategic flexibility. million price tag.
60 
Let's personalize your content